Pharmaceutical manufacturing company, Institute of Drug Technology (IDT) Australia, has announced via an ASX announcement, that it has been granted a Medicinal Cannabis Manufacturing Licence from the Department
Read More
Victoria set to grow as a pharmaceutical hub
After claiming the title as the national hub of medicinal cannabis, Victoria is now set to win the title for a global centre for medicinal opium poppies, as the state focuses on growing its pharmaceutical
Read More
Read More
Mayne Pharma opens new $80m US manufacturing facility
Pharmaceutical company Mayne Pharma has announced launching an $80-million, oral solid-dose commercial manufacturing facility in Greenville, North Carolina.
Mayne Pharma’s new 126,000-square-foot (11,700
Read More
Read More
NSW manufacturers unite to develop world-first PET diagnostics
Pharmaceutical manufacturers Cyclotek and Cyclopharm have entered an agreement with Macquarie University to advance the Australian molecular imaging sector.
The research will also involve radiopharmaceutical
Read More
Read More
AISC’s new training package for pharma manufacturing businesses
The Australian Industry and Skills Committee (AISC) has introduced a new training package to ensure VET meets the needs of industry by having industry involved in training development. The AISC is advised
Read More
Read More
Sensor for chemical and pharmaceutical industries
Hoffmann-Krippner has announced the availability of the EHEDG (European Hygienic Engineering and Design Group) certified hygienic mounting kit for PiL’s P53 Steel Head ultrasonic sensors.
This new, off-the-shelf,
Read More
Read More
NSW pharmaceutical manufacturer creates eight new jobs
Nowchem has opened its $450,000 redeveloped pharmaceutical manufacturing facility at the Flinders Industrial Estate in Shoalhaven. The redevelopment has created eight new ongoing jobs at the facility.
According
Read More
Read More
Nurofen maker slapped with $1.7 million in penalties for misleading claims
Ansell profit down
Protective clothing and condom maker Ansell has posted a 21 per cent fall in first half profit as a result of weakening economic conditions.
Read More
Read More
New manufacturing method could see cheaper vaccines produced in Melbourne
UK pharmaceutical company GlaxoSmithKline has opened a new pilot plant to trial a promising vaccine storage method developed by the company, an Australian university and Belgian researchers.
Read More
Read More
Siemens becomes a strategic automation partner for GlaxoSmithKline
Siemens and GlaxoSmithKline, one of the world’s leading research-based
pharmaceutical and healthcare companies, have entered a global strategic
partnership.
Read More
Read More
Novogen to conduct company-wide review
The acting CEO of drug manufacturer Novogen has announced a review into all the company's operations including its pre-clinical trials.
Read More
Read More
Cell Therapy Manufacturing Cooperative Research Centre links research and industry
Australia’s first cell therapy manufacturing centre is bridging the gap between cell research in the lab.
Read More
Read More
Novogen announces $30.5m capital raising following cancer research
Australian biotech Novogen wants $30.5m from investors as it plans to enter a major growth phase and continues its successful cancer research.
Read More
Read More
Novogen shares surge after successful cancer research
Shares in drug manufacturer Novogen rose 40 per cent after the company announced the results of a successful cancer drug study.
Read More
Read More
META announces Best Practices in Biopharma hub
META has announced a collaborative project involving Hospira, GlaxoSmithKline and CSL aiming to increase the effectiveness of manufacturing.
Read More
Read More
Hospira calls for industry minister to lead medicines manufacturing taskforce
Industry minister Ian Macfarlane has inspected the progress at a line upgrade at Hospira’s Mulgrave plant.
Read More
Read More
Samsung to manufacture commercial drug substances for Bristol-Myers Squibb
Samsung had earlier claimed they manufacture biosimilars at half the cost of what Western drugmakers would have to charge.
Read More
Read More
Drug manufacturers may be forced into “pay for performance” model
A government committee has recommended that the companies who manufacture two drugs be forced into a “pay for performance” model.
Read More
Read More
Pharmaceuticals growth hurt by patent expiries, rationalisation
The expiration of patents, industry restructuring and other factors will put a squeeze on the pharmaceutical industry, according to a new report.
Read More
Read More